Six in 10 Americans identify lowering the cost of prescription drugs as a “top priority” for President Trump and Congress when it comes to health care, according to a recent poll by the Kaiser Family Foundation. When asked about specific proposals to hold down drug costs, a majority of adults support allowing the federal government to negotiate with drug companies to lower prices for Medicare beneficiaries (92%); making it easier for generic drugs to come to market (87%); requiring drug companies to release information on how they set prices (86%); limiting what drug companies can charge for certain high-cost drugs (78%); allowing Americans to buy drugs imported from Canada (72%); and creating an independent group to oversee drug pricing (72%).

Related News Articles

Headline
The Senate Committee on Health, Education, Labor and Pensions today held the second in a series of hearings on the cost of prescription drugs. “We…
Headline
Baxter Healthcare Corp., in coordination with the Food and Drug Administration, has agreed to temporarily import certain intravenous drug products, such…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
Hospitals generally support the proposed cancellation of the cardiac and Surgical Hip and Femur Fracture Treatment bundling program and Comprehensive Care for…
Headline
Twenty-three organizations, including the AHA, Friday urged the Centers for Medicare & Medicaid Services to suspend implementation of new draft Medicare…
Headline
The Centers for Medicare & Medicaid Services has identified the first clinicians eligible to participate in 2018 advanced alternative payment models, based…